165 related articles for article (PubMed ID: 19556319)
1. Disseminated tumor cells and the risk of locoregional recurrence in nonmetastatic breast cancer.
Bidard FC; Kirova YM; Vincent-Salomon A; Alran S; de Rycke Y; Sigal-Zafrani B; Sastre-Garau X; Mignot L; Fourquet A; Pierga JY
Ann Oncol; 2009 Nov; 20(11):1836-41. PubMed ID: 19556319
[TBL] [Abstract][Full Text] [Related]
2. Disseminated Tumor Cells Predict Efficacy of Regional Nodal Irradiation in Early Stage Breast Cancer.
Mignot F; Loirat D; Dureau S; Bataillon G; Caly M; Vincent-Salomon A; Berger F; Fourquet A; Pierga JY; Kirova YM; Bidard FC
Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):389-396. PubMed ID: 30291993
[TBL] [Abstract][Full Text] [Related]
3. Detection of disseminated tumor cells in locally advanced breast cancer patients before primary systemic therapy.
Solá M; Margelí M; Castellá E; Cirauqui B; Mariscal A; Rull M; Julian JF; Luna M; Vallejo V; Fraile M
Breast; 2013 Oct; 22(5):908-13. PubMed ID: 23683695
[TBL] [Abstract][Full Text] [Related]
4. Disseminated tumor cells from the bone marrow of patients with nonmetastatic primary breast cancer are predictive of locoregional relapse.
Hartkopf AD; Wallwiener M; Fehm TN; Hahn M; Walter CB; Gruber I; Brucker SY; Taran FA
Ann Oncol; 2015 Jun; 26(6):1155-1160. PubMed ID: 25791636
[TBL] [Abstract][Full Text] [Related]
5. Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse.
Bidard FC; Vincent-Salomon A; Gomme S; Nos C; de Rycke Y; Thiery JP; Sigal-Zafrani B; Mignot L; Sastre-Garau X; Pierga JY;
Clin Cancer Res; 2008 Jun; 14(11):3306-11. PubMed ID: 18519757
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of nodal involvement region in clinical stage IIIc breast cancer patients who received primary systemic treatment, surgery, and radiotherapy.
Noh JM; Kim KH; Park W; Suh CO; Huh SJ; Choi DH; Keum KC; Kim YB
Breast; 2015 Oct; 24(5):637-41. PubMed ID: 26283599
[TBL] [Abstract][Full Text] [Related]
7. Postmastectomy radiotherapy improves disease-free survival of high risk of locoregional recurrence breast cancer patients with T1-2 and 1 to 3 positive nodes.
He ZY; Wu SG; Zhou J; Li FY; Lin Q; Lin HX; Sun JY
PLoS One; 2015; 10(3):e0119105. PubMed ID: 25781605
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancer.
Naume B; Synnestvedt M; Falk RS; Wiedswang G; Weyde K; Risberg T; Kersten C; Mjaaland I; Vindi L; Sommer HH; Sætersdal AB; Rypdal MC; Bendigtsen Schirmer C; Wist EA; Borgen E
J Clin Oncol; 2014 Dec; 32(34):3848-57. PubMed ID: 25366688
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of disseminated tumor cells in the bone marrow of patients with operable primary breast cancer: a long-term follow-up study.
Domschke C; Diel IJ; Englert S; Kalteisen S; Mayer L; Rom J; Heil J; Sohn C; Schuetz F
Ann Surg Oncol; 2013 Jun; 20(6):1865-71. PubMed ID: 23263703
[TBL] [Abstract][Full Text] [Related]
10. Prognostic relevance of disseminated tumour cells from the bone marrow of early stage breast cancer patients - results from a large single-centre analysis.
Hartkopf AD; Taran FA; Wallwiener M; Hahn M; Becker S; Solomayer EF; Brucker SY; Fehm TN; Wallwiener D
Eur J Cancer; 2014 Oct; 50(15):2550-9. PubMed ID: 25096167
[TBL] [Abstract][Full Text] [Related]
11. Disseminated Tumor Cells in the Bone Marrow of Patients with Operable Primary Breast Cancer: Prognostic Impact in Immunophenotypic Subgroups and Clinical Implication for Bisphosphonate Treatment.
Stefanovic S; Diel I; Sinn P; Englert S; Hennigs A; Mayer C; Schott S; Wallwiener M; Blumenstein M; Golatta M; Heil J; Rom J; Sohn C; Schneeweiss A; Schuetz F; Domschke C
Ann Surg Oncol; 2016 Mar; 23(3):757-66. PubMed ID: 26467455
[TBL] [Abstract][Full Text] [Related]
12. Mitotic activity and bone marrow micrometastases have independent prognostic value in node positive breast cancer patients.
Gilje B; Nordgård O; Tjensvoll K; Janssen EA; Søiland H; Smaaland R; Baak JP
Breast Cancer Res Treat; 2011 Jul; 128(1):137-46. PubMed ID: 21476002
[TBL] [Abstract][Full Text] [Related]
13. Disseminated tumor cells and their prognostic significance in nonmetastatic prostate cancer patients.
Lilleby W; Stensvold A; Mills IG; Nesland JM
Int J Cancer; 2013 Jul; 133(1):149-55. PubMed ID: 23280694
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the prognostic significance of disseminated tumor cells in the bone marrow of primary, non-metastatic breast cancer patients after a 7-year follow-up.
Hoffmann O; Schroer-Zuendorf IA; Kasimir-Bauer S; Oberhoff C; Kimmig R; Heubner M
Arch Gynecol Obstet; 2015 Nov; 292(5):1117-25. PubMed ID: 25986892
[TBL] [Abstract][Full Text] [Related]
15. Presence of disseminated tumor cells in bone marrow correlates with tumor stage and nodal involvement in cervical cancer patients.
Fehm T; Banys M; Rack B; Jäger B; Hartkopf A; Taran FA; Janni W
Int J Cancer; 2014 Feb; 134(4):925-31. PubMed ID: 23921989
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant systemic therapy alone: patterns of recurrence.
Fisher BJ; Perera FE; Cooke AL; Opeitum A; Venkatesan V; Dar AR; Stitt L
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):541-50. PubMed ID: 9231678
[TBL] [Abstract][Full Text] [Related]
17. Outcome of postmastectomy radiotherapy after primary systemic treatment in patients with clinical T1-2N1 breast cancer.
Cao L; Ou D; Shen KW; Cai G; Cai R; Xu F; Zhao SG; Xu C; Grellier Adedjouma N; Kirova YM; Chen JY
Cancer Radiother; 2018 Feb; 22(1):38-44. PubMed ID: 29306555
[TBL] [Abstract][Full Text] [Related]
18. Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy.
Bijker N; Rutgers EJ; Peterse JL; van Dongen JA; Hart AA; Borger JH; Kroon BB
Cancer; 1999 Apr; 85(8):1773-81. PubMed ID: 10223572
[TBL] [Abstract][Full Text] [Related]
19. Pooled analysis of the prognostic relevance of disseminated tumor cells in the bone marrow of patients with ovarian cancer.
Fehm T; Banys M; Rack B; Janni W; Marth C; Blassl C; Hartkopf A; Trope C; Kimmig R; Krawczyk N; Wallwiener D; Wimberger P; Kasimir-Bauer S
Int J Gynecol Cancer; 2013 Jun; 23(5):839-45. PubMed ID: 23694981
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for breast cancer patients with T1-2 tumor and 1-3 positive axillary nodes treated using total mastectomy without radiotherapy.
Asaga S; Kinoshita T; Shiino S; Jimbo K; Takayama S
Breast J; 2019 Jan; 25(1):26-33. PubMed ID: 30414218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
